Mindwalk Holdings CORP. (HYFT) — 6-K Filings

All 6-K filings from Mindwalk Holdings CORP.. Browse 50 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (50)

MindWalk Holdings Corp. Files 6-K with Earnings Release — Dec 15, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on December 15, 2025, to report its earnings release dated December 15, 2025.
6-K Filing — Dec 8, 2025
MindWalk Holdings Corp. Files 6-K with Nov 13 Press Release — Nov 13, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on November 13, 2025, reporting a press release dated November 13, 2025. The c
6-K Filing — Nov 7, 2025
MindWalk Holdings Corp. Files 6-K with Executive Comp Update — Nov 6, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on November 6, 2025. This report includes a revised Statement of Executive Com
MindWalk Holdings Corp. Files 6-K with Press Release — Oct 21, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on October 21, 2025, reporting a press release dated October 21, 2025. The com
MindWalk Holdings Corp. Files 6-K Report — Oct 15, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on October 15, 2025, reporting information as of that date. The filing include
MindWalk Holdings Corp. Files 6-K with Pro Forma Financials — Oct 14, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on October 14, 2025, reporting for the month of October 2025. The filing inclu
MindWalk Holdings Corp. Files 6-K with October Press Release — Oct 9, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on October 9, 2025, reporting on its activities for the month of October 2025.
MindWalk Holdings Corp. Files 6-K Report — Sep 22, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on September 22, 2025, reporting on its activities for the month of September
MindWalk Holdings Corp. Files 6-K with Financial Data — Sep 15, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a 6-K report on September 15, 2025, for the period ending July 31, 2025. The filing inclu
MindWalk Holdings Corp. Files 6-K, Reports Press Release — Sep 10, 2025 Risk: low
MindWalk Holdings Corp. (formerly ImmunoPrecise Antibodies Ltd.) filed a Form 6-K on September 10, 2025, reporting a press release dated September 10, 2025. The
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Sep 3, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on September 3, 2025, reporting a press release dated September 3, 2025. The filing indicates the company is a fo
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Sep 2, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on September 2, 2025, reporting on activities for the month of September 2025. The filing includes a press releas
ImmunoPrecise Antibodies Ltd. Files 6-K — Aug 27, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on August 27, 2025, reporting a press release dated August 27, 2025. The filing indicates the company is a foreig
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Aug 6, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on August 6, 2025, reporting a press release dated August 6, 2025. The filing indicates the company is a foreign
ImmunoPrecise Antibodies Ltd. Files 6-K for Meeting Notice — Aug 1, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on August 1, 2025, to report a Notice of Meeting and Record Date dated August 1, 2025. The company, with its prin
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jul 29, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 29, 2025, to report a press release dated July 29, 2025. The company, headquartered in Austin, Texas, is
ImmunoPrecise Antibodies Ltd. Files 6-K — Jul 24, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 24, 2025, reporting a press release dated July 24, 2025. The filing indicates the company is a foreign pr
ImmunoPrecise Antibodies Ltd. Files 6-K — Jul 21, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 21, 2025, to report a press release dated July 21, 2025. The filing does not contain specific financial f
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Jul 14, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 14, 2025, to report a press release dated July 14, 2025. The filing indicates the company is a foreign pr
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Jul 7, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 7, 2025, reporting a press release dated July 7, 2025. The filing indicates the company is a foreign priv
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jul 3, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on July 3, 2025, to report a press release dated July 3, 2025. The filing does not contain specific financial fig
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jun 24, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 24, 2025, to report a press release dated June 24, 2025. The filing does not contain specific financial f
ImmunoPrecise Antibodies Files 6-K with Press Release — Jun 12, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 12, 2025, reporting a press release dated June 12, 2025. The filing indicates the company is a foreign pr
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jun 5, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on June 5, 2025, to report a press release dated June 5, 2025. The filing indicates the company is a foreign priv
ImmunoPrecise Antibodies Files 6-K with Press Release — May 21, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on May 21, 2025, to report a press release dated May 21, 2025. The filing indicates the company is a foreign priv
ImmunoPrecise Antibodies Ltd. Files 6-K Report — May 12, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on May 12, 2025, reporting a press release dated May 12, 2025. The filing indicates the company is a foreign priv
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Apr 11, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on April 11, 2025, reporting a press release dated April 11, 2025. The filing indicates the company is a foreign
ImmunoPrecise Antibodies Ltd. Files 6-K with SEC — Apr 10, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on April 10, 2025, incorporating by reference several press releases and a registration statement. The filing inc
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Mar 28, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a 6-K report on March 28, 2025, for the period ending January 31, 2025. The filing includes financial data related to variou
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Mar 13, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on March 13, 2025, incorporating a press release dated March 13, 2025, as Exhibit 99.1. This filing is related to
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Mar 12, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on March 12, 2025, incorporating a press release dated March 12, 2025, as Exhibit 99.1. This filing is incorporat
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Feb 24, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on February 24, 2025, incorporating a press release dated February 24, 2025, as Exhibit 99.1. This filing is rela
ImmunoPrecise Antibodies Ltd. Clarifies Share Count — Feb 3, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed an amendment to its January 2025 Form 6-K on February 3, 2025. The amendment's sole purpose is to add a sentence to a previo
ImmunoPrecise Antibodies Files 6-K with Press Release — Jan 27, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on January 27, 2025, reporting a press release dated January 27, 2025. The filing indicates the company is a fore
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Jan 22, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on January 22, 2025, to report a press release dated January 22, 2025. The filing indicates the company is a fore
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jan 17, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on January 17, 2025, reporting on its activities for the month of January 2025. The filing includes a press relea
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Jan 3, 2025 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on January 3, 2025, incorporating by reference a Material Change Report dated January 2, 2025. This filing is rel
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Dec 23, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on December 23, 2024, to report information for the month of December 2024. The filing includes a press release d
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Dec 3, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on December 3, 2024, to report a press release dated December 3, 2024. The filing does not contain specific finan
ImmunoPrecise Antibodies Ltd. Files AGM Voting Results — Nov 18, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on November 18, 2024, reporting voting results from their AGM held on November 15, 2024. The filing incorporates
ImmunoPrecise Antibodies Ltd. Files 6-K with Press Release — Nov 13, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on November 13, 2024, to report a press release dated November 13, 2024. The filing indicates the company is a fo
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Nov 4, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on November 4, 2024, to report a press release dated November 4, 2024. The filing does not contain specific finan
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Oct 28, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 28, 2024, to report a press release dated October 28, 2024. The filing indicates the company is a fore
ImmunoPrecise Antibodies Ltd. Files October 2024 6-K Report — Oct 24, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 24, 2024, reporting for the month of October 2024. The filing was signed by Kristin Taylor, Chief Fina
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Oct 21, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 21, 2024, to report a press release dated October 21, 2024. The filing does not contain specific finan
ImmunoPrecise Antibodies Ltd. Files Form 6-K — Oct 11, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 11, 2024, reporting for the month of October 2024. The filing includes an Amended Notice of Annual Gen
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Oct 10, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 10, 2024, to report a press release dated October 10, 2024. The filing indicates the company is a fore
ImmunoPrecise Antibodies Ltd. Files 6-K Report — Oct 2, 2024 Risk: low
ImmunoPrecise Antibodies Ltd. filed a Form 6-K on October 2, 2024, to report a press release dated October 2, 2024. The filing indicates the company is a foreig

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX